
Tharimmune Investor Relations Material
Latest events

Q1 2025
11 May, 2025

Q4 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tharimmune Inc
Access all reports
Tharimmune Inc. is a biopharmaceutical company focused on the development of immune-modulating therapies for inflammatory diseases and cancer. The company specializes in small molecule and biologic drug candidates designed to regulate immune responses and target disease pathways. Tharimmune conducts clinical research and drug development to address unmet medical needs in autoimmune disorders, oncology, and fibrosis-related conditions. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.
Key slides for Tharimmune Inc


Corporate Presentation
Tharimmune Inc


Corporate Presentation
Tharimmune Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
THAR
Country
🇺🇸 United States